Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-CH1/CL) (BSCC-014)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-B cell lymphoma 38C13 Idiotype antibody variable domain is fused to CH1 and the other scFv from an anti-LFA-1 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

B cell lymphoma 38C13 Idiotype & LFA-1

Type

scFv-CH1/CL

Species Reactivity

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma

Targets

Target 1

B cell lymphoma 38C13 Idiotype

Alternative Names

B cell lymphoma 38C13 Idiotype; B cell lymphoma; 38C13 ; Idiotype; Id

Target 2

LFA-1

Gene ID

16414

UniProt ID

P24063

Alternative Names

integrin subunit alpha L; Integrin beta chain-2; ITGB2; Integrin subunit beta 2; MF17, MAC-1; ITGAL; CD11A; LFA-1; LFA1A; ITGAL; CD18; LCAMB; AI528527; 2E6; LAD

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "B cell lymphoma 38C13 Idiotype & LFA-1"

See other bsAb targets related to "B cell lymphoma 38C13 Idiotype"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-CH1/CL) (BSCC-014). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-014)

Specifications

Targets

Customer Reviews and Q&As